What it's for (Indications)
- Econazole nitrate cream is indicated for topical application in the treatment of cutaneous candidiasis (moniliasis), tinea corporis, tinea cruris, and tinea pedis caused by susceptible organisms, including *Candida albicans*, *Trichophyton mentagrophytes*, *Epidermophyton floccosum*, and *Microsporum canis*.
- It is also effective in the treatment of tinea versicolor caused by *Malassezia furfur* (formerly *Pityrosporum orbiculare*).
- This broad-spectrum imidazole antifungal agent effectively targets a range of dermatophytic fungi and yeasts that commonly cause superficial skin infections, providing symptomatic relief and mycological cure.
- Treatment duration varies based on the specific condition and severity, typically ranging from 2 to 4 weeks, to ensure complete eradication of the fungal pathogen and prevent recurrence.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For adults and children, econazole nitrate cream should be applied to the affected areas once or twice daily, depending on the specific infection and physician's recommendation. A sufficient quantity should be gently massaged into the skin until it is fully absorbed. For tinea pedis, tinea cruris, and tinea corporis, treatment usually continues for 2 to 4 weeks. Cutaneous candidiasis often requires 2 weeks of treatment, while tinea versicolor typically resolves with 2 weeks of once-daily application. It is crucial to continue treatment for the full prescribed duration, even if clinical symptoms improve, to ensure complete eradication of the infection, prevent relapse, and minimize the risk of developing antifungal resistance. If no clinical improvement is observed after the prescribed course, the diagnosis should be re-evaluated. |
Safety & Warnings
Common Side Effects
- The most commonly reported side effects associated with topical econazole nitrate cream are localized skin reactions at the application site.
- These include burning, stinging, itching (pruritus), redness (erythema), and generalized irritation.
- These reactions are usually mild and transient, often resolving with continued use or after discontinuation.
- Less frequently, patients may experience contact dermatitis, rash, or folliculitis.
- Systemic side effects are rare due to minimal percutaneous absorption of econazole following topical application.
- However, should severe irritation, sensitization, or an allergic reaction (e.
- g.
- , urticaria, angioedema) occur, treatment should be discontinued immediately, and a healthcare professional consulted for alternative management and symptomatic relief.
- Patients should be advised to report any persistent or worsening adverse reactions.
Serious Warnings
- Black Box Warning: **Serious Warnings**: Econazole nitrate cream does not carry an official FDA Black Box Warning. However, healthcare professionals and patients should be aware of several important safety considerations that warrant careful attention. Serious hypersensitivity reactions, including severe irritation, rash, urticaria, and angioedema, although rare, can occur. If such reactions develop, treatment must be immediately discontinued, and appropriate medical intervention sought. The cream is for external dermatological use only and must not be used in the eyes, mouth, or other mucous membranes. Accidental ingestion or ophthalmic exposure should prompt immediate medical evaluation. Persistent or worsening irritation, or lack of clinical improvement after the recommended treatment period, necessitates re-evaluation of the diagnosis and treatment plan, as this could indicate a resistant infection, an incorrect diagnosis, or an underlying medical condition. Patients should be advised to contact their healthcare provider if they experience any severe or unexpected adverse effects during treatment.
- Econazole nitrate cream is for external dermatological use only and should not be used orally, intravaginally, or ophthalmically.
- Care should be taken to avoid contact with eyes and other mucous membranes; if accidental contact occurs, the affected area should be rinsed thoroughly with water.
- Discontinue use if irritation, sensitization, or chemical cellulitis develops during treatment, and consult a physician for further assessment.
- Patients should be advised about the importance of completing the full course of therapy, even if symptoms improve, to prevent recurrence and the potential development of antifungal resistance.
- Use in pregnant or lactating women should only be considered if the potential benefits justify the potential risks, as systemic absorption, though minimal, is possible.
- Pediatric use should be under medical supervision, especially for extensive areas of application.
How it Works (Mechanism of Action)
Econazole is an imidazole antifungal agent that exerts its fungicidal and fungistatic effects by interfering with the biosynthesis of ergosterol, a crucial component of the fungal cell membrane. Specifically, it inhibits 14-alpha-demethylase, a cytochrome P450 enzyme responsible for converting lanosterol to ergosterol. This inhibition leads to the accumulation of 14-alpha-methyl sterols and a depletion of ergosterol within the fungal membrane. The resulting structural disorganization impairs the integrity and function of the fungal cell membrane, increasing its permeability. This increased permeability leads to the leakage of essential intracellular components such as potassium ions, amino acids, and purines, ultimately resulting in fungal cell death. This mechanism provides a broad spectrum of activity against dermatophytes, yeasts, and other pathogenic fungi.
Commercial Brands (Alternatives)
No other brands found for this formula.